Laurion Capital Management’s Revolution Medicines RVMD Stock Holding History

Laurion Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-19,747	Closed	-$726K	–	418
2025 Q2	$726K	Buy	+19,747	New	+$759K	0.01%	223
2021 Q2	–	Sell	-10,000	Closed	-$459K	–	924
2021 Q1	$459K	Hold	10,000	–	–	﹤0.01%	600
2020 Q4	$396K	Hold	10,000	–	–	﹤0.01%	512
2020 Q3	$348K	Hold	10,000	–	–	﹤0.01%	635
2020 Q2	$316K	Hold	10,000	–	–	﹤0.01%	716
2020 Q1	$219K	Buy	+10,000	New	+$277K	﹤0.01%	667

Other funds holding RVMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Laurion Capital Management's RVMD Position: Q3 2025 in Review

Laurion Capital Management sold out of Revolution Medicines (RVMD) in Q3 2025, closing a stake of 19,747 shares — an estimated $726K sold.

Laurion Capital Management first reported a position in RVMD in Q1 2020 and held it in 6 quarters. The position peaked at $726K in Q2 2025. 323 funds tracked by Wall St. Rank hold RVMD as of Q3 2025.

Laurion Capital Management reported no remaining Revolution Medicines position as of Q3 2025 after selling out during the quarter.
Laurion Capital Management sold 19,747 Revolution Medicines shares in Q3 2025, an estimated $726K.
Laurion Capital Management first reported a position in Revolution Medicines in Q1 2020 and held it in 6 quarters.
Laurion Capital Management's Revolution Medicines position peaked at $726K in Q2 2025.
323 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2025.

Based on Laurion Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.